Taken by Marcela

The PenTAG and Fiocruz researchers taking part in the first collaborative workshop

PenTAG’s collaboration with infectious disease researchers in Brazil takes off

Following success in gaining an MRC Newton Fund grant (PI: Prof. Chris Hyde), PenTAG researchers have linked with Fiocruz (the Oswaldo Cruz Foundation) in Brazil, and taken part in the first collaborative workshop at the Fiocruz research campus in Rio de Janeiro.  Fiocruz is the largest institute of public health research in the southern hemisphere, a leading research partner of Brazil’s Ministry of Health, and has been making globally important discoveries about the biology and prevention of infectious diseases since the early 20th century.

From the 11th to the 15th of May 2015, seven PenTAG researchers with expertise in health technology assessment ran an introductory workshop on health technology assessment for clinical and public health researchers at Fiocruz.  In two other meetings during the week, we worked together on a project to develop an assessment of the cost-effectiveness of new diagnostics technologies for liver fibrosis, and new antiviral drugs for treating Hepatitis C, which affects almost one million people in Brazil.

Our trip was extremely successful, and generously hosted by Dr Rodolfo Castro of the Evandro Chagas Institute for Clinical Research (IPEC) and the Center for Technological Development in Health (CDTS).  We look forward to welcoming members of the Fiocruz team to Exeter later in 2015.

Prof Chris Hyde said of this first trip and workshop to initiate the collaboration: “The trip greatly exceeded our expectations on what could be achieved in such a short time; it augurs well for future collaboration on health technology assessments, particularly of new diagnostics in infectious disease”.

Other members of the team who delivered the workshop and participated in the systematic review and model development meetings were: Chris Cooper, Marcela Haasova, Harriet Hunt, Jo Varley-Campbell, Rob Anderson, Louise Crathorne (UEMS Health Economics Group) and Mariana Bacelar (BMJ-TAG)